Clinic
First Care LLC
First Care LLC was paid $812K by Medicaid between Jan 2018 and Nov 2024, across 34 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoFIRST CARE LLC
TUSCALOOSA, AL 35406
TUSCALOOSA, AL 35406
33aNPI1164767083assigned 12/04/2012
33bProvider typeUrgent Care Clinic/Center
28Total paid$812K
24GClaims43,384
24DCodes billed34
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Alabama
Rank by total paid#11 of 59
Median peer was paid$77K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 441 | $1K | |
| 2019 | 232 | $3K | |
| 2020 | 229 | $8K | |
| 2021 | 11,931 | $257K | |
| 2022 | 22,297 | $418K | |
| 2023 | 5,838 | $107K | |
| 2024incomplete | 2,416 | $19K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 4,717 | 3,993 | $240K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 21% | 2,025 | 1,840 | $167K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 12% | 4,639 | 4,120 | $96K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.1% | 1,865 | 1,584 | $66K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 7.6% | 7,362 | 3,312 | $61K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.9% | 3,720 | 3,238 | $32K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.9% | 518 | 479 | $31K |
| 87428 | 3.0% | 593 | 540 | $25K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.0% | 2,239 | 2,040 | $24K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.5% | 2,797 | 2,306 | $21K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 606 | 535 | $9K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.1% | 506 | 404 | $9K |
22 more codes
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.0% | 333 | $8K |
| 87807 | <1% | 868 | $8K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 265 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 417 | $3K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 56 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 33 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 847 | $1K |
| 81002 | <1% | 577 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,403 | $513.62 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 173 | $232.31 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 26 | $170.00 |
| 81025 | <1% | 58 | $95.20 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 327 | $28.18 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 397 | $0.52 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 415 | $0.13 |
| 1125F | 0% | 70 | $0.00 | |
| 3008F | 0% | 5,120 | $0.00 | |
| 1170F | 0% | 267 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 40 | $0.00 |
| 1159F | 0% | 33 | $0.00 | |
| 1494F | 0% | 39 | $0.00 | |
| 1160F | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPERAMSETTY, SASANK (MEDICAL DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Crimson Care LLC | Tuscaloosa, AL | $1.50M |
| Crimson Urgent Care, LLC | Tuscaloosa, AL | $1.45M |
| First Kids | Tuscaloosa, AL | $1.35M |
| Alabama Family Medical Center, LLC | Tuscaloosa, AL | $168K |
| Crimson Care North | Northport, AL | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.